The Brazilian Journal of Infectious Diseases

ISSN: 1413-8670

The Brazilian Journal of Infectious Diseases is the official publication of the Brazilian Society of Infectious Diseases (SBI). It aims to publish relevant articles in the broadest sense on all aspects of microbiology, infectious diseases and immune response to infectious agents.
The BJID is a bimonthly publication and one of the most influential journals in its field in Brazil and Latin America with a high impact factor. Since its inception it has garnered a growing share of the publishing market.

Indexed in:

CABI Publishing; Chemical Abstracts (CAS); China Education Publications Import and Export Corporation (CEPIEC); EBSCO Database (Premium Research); Elsevier Science - Bibliographic Databases Division; Embase/Excerpta Medica; Gale Cengage Learning; Index Copernicus International; ISI (Web of Science) - Science Citation Index Expanded (SCISEARCH); Journal Citation Reports (Science Edition); Kessler-Hancok Information Service; Latin America and Caribean Literature of Health Science (LILACS); LATINDEX; Medline/ Index Medicus/Pubmed; Qualis International (CAPES): B3 (International Quality); Redalyc (Network of Scientific Journals of Latin America, Caribbean, Spain and Portugal) SCIELO; SCIRUS (Elsevier); SCOPUS Index; Sociedad Iberoamericana de Información Cientifica (SIIC); Subis Database (SUBIS Bulletin); Swets Blackwell; Teldan Database Production; The US Library of Congress Office; Ulrich¿s Periodicals Directory.

Special content about coronavirus SARS-CoV-2 (COVID-19) in The Brazilian Journal of Infectious Diseases

Does sensitization by SARS-CoV-2 immune complexes trigger DRESS syndrome?

Virgínia Barbeitos Cruz, Luiz Fernando Fróes Fleury Júnior, Christiane Reis Kobal, Nilzio Antonio da Silva

10.1016/j.bjid.2022.102337

Braz J Infect Dis. 2022;26:

Open access

Evaluation of the Panbio™ COVID-19 ag rapid test at an emergency room in a hospital in São Paulo, Brazil

Klinger Soares Faíco-Filho, Francisco Estivallet Finamor Júnior, Luiz Vinícius Leão Moreira, Paulo Ricardo Gessolo Lins, Alberto Fernando Oliveira Justo, Nancy Bellei

10.1016/j.bjid.2022.102349

Braz J Infect Dis. 2022;26:

Open access

The effect of favipiravir versus hydroxychloroquine on clinical and laboratory findings in COVID-19 in healthcare workers

Derya Bayırlı Turan, Mehtap Menteş, Yıldıran Özel, Kıvanç Şerefhanoğlu, Burcu Aydoğan, Neşe İbil, Füsun Güneşdoğdu, Hijran Mammadova Orucova, Cüneyt Saltürk, Hakan Çelik

10.1016/j.bjid.2022.102328

Braz J Infect Dis. 2022;26:

Open access

Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study

Giovanni Dolci, Giulia Cassone, Giulia Besutti, Romina Corsini, Fabio Sampaolesi, Valentina Iotti, Elena Galli, Adalgisa Palermo, Matteo Fontana, Pamela Mancuso

10.1016/j.bjid.2021.101702

Braz J Infect Dis. 2022;26:

Open access

Diagnostic performance of the RSNA-proposed classification for COVID-19 pneumonia versus pre-pandemic controls

Cauã O. Rocha, Tássia A.D. Prioste, Carlo S. Faccin, Luciano Folador, Mateus S. Tonetto, Pedro G. Knijnik, Natalia B. Mainardi, Rogério B. Borges, Tiago S. Garcia

10.1016/j.bjid.2021.101665

Braz J Infect Dis. 2022;26:

Open access

OTIMIZAÇÃO DA TERAPIA COM A VANCOMICINA NOS PACIENTES CRÍTICOS ONCOLÓGICOS EM TERAPIA INTENSIVA CONTRA GRAM-POSITIVOS ATÉ CIM 2 MG/L BASEADA NA ABORDAGEM FARMACOCINÉTICA-FARMACODINÂMICA (PK/PD)

Estela Maris de Oliveira, Juliano Pinheiro de Almeida, João M. Silva Junior, Thais Vieira de Camargo, Alberto H. Sabanai, Rejane S. Siqueira, Julia David P. Silva, Suely Pereira Zeferino, David S. Gomez, Silvia R.C.J. Santos

10.1016/j.bjid.2021.101759